Opinion

Opinion

Interactive Data Dashboards

Track the HIV & TB response

Live indicators, province breakdowns and downloadable data.

  • SA cannot end TB while tobacco and nicotine addiction go unchecked

    If South Africa is serious about ending TB, protecting people living with HIV, and safeguarding the next generation from nicotine addiction, Parliament must finally pass the Tobacco Products and Electronic Delivery Systems Control Bill, argues Professor Lekan Ayo-Yusuf, as we mark World No Tobacco Day on May 31.

    ·

  • What the law actually says about migrants’ right to access healthcare in SA

    The media has reported several incidents where people were turned away at public healthcare facilities because they did not possess South African identity documents. As related cases slowly grind through the courts, Teri Brown and Thembi Mahlathi of SECTION27 connect the dots between what the law says and what people are experiencing.

    ·

  • As NHI stalls, the real debate is about trade offs

    Healthcare funding is always about trade-offs, writes Thoneshan Naidoo, CEO of the Health Funders Association. The hardest question in healthcare is not what we would like to provide, he argues, but what we can provide sustainably, fairly and at scale.

    ·

  • After centuries, TB is still the bridesmaid, never the bride

    The wins are there but the underlying reality remains, writes Professor Kogie Naidoo as she likens TB to a bridesmaid awaiting its turn to garner attention. The analogy is relevant given the overwhelming number of new TB infections and deaths each year globally for a disease persistently sitting in the shadow of other communicable and…

    ·

  • The fight against TB is also the fight for human rights

    The persistence of TB is a reminder that medical solutions alone are not enough. Renier Coetzee and Ingrid Schoeman write that the disease thrives in conditions shaped by social injustice, including poverty, overcrowded housing, under-resourced health systems, and unequal access to care.

    ·

  • The hunt for a new TB vaccine: Why we are now so close, and why it matters

    The only tuberculosis vaccine we have is a century old and offers only limited efficacy in children. With leading South African researchers involved in the pivotal clinical trials of three new tuberculosis vaccine candidates, we are on the verge of a major breakthrough, writes Associate Professor Angelique Kany Kany Luabeya.

    ·

  • A new TB dashboard can help boost testing. We need to make the most of it

    The new government TB dashboard is a step forward for transparency and accountability in South Africa’s response to the ancient, but still deadly, disease. It is critical that we use it wisely to boost our testing efforts, argues a group of South Africa’s leading TB activists ahead of World TB Day on March 24th.

    ·